Clinical Trial Update: Nitrocamptothecin Compared With Other Chemotherapy in Treating Patients With Recurrent or Refractory Cancer of the Pancreas [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Nitrocamptothecin versus other chemotherapy in pancreatic cancer; the update provides no trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Nitrocamptothecin (nitrocamptothecin)

Snippet

Sponsor: Astex Pharmaceuticals, Inc. | Conditions: Pancreatic Cancer | Phase 3 | Status: UNKNOWN